Page last updated: 2024-08-24

fradafiban and Blood Clot

fradafiban has been researched along with Blood Clot in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byrne, A; Crean, P; Fitzgerald, DJ; Maher, M; Moran, N; Walsh, N1

Trials

1 trial(s) available for fradafiban and Blood Clot

ArticleYear
Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biphenyl Compounds; Bleeding Time; Cell Division; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Muscle, Smooth, Vascular; P-Selectin; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Thromboxane A2; Thromboxane B2; Vasoconstriction

1997

Other Studies

1 other study(ies) available for fradafiban and Blood Clot

ArticleYear
Fradafiban. BIBU 52, BIBU 52 ZW.
    Drugs in R&D, 1999, Volume: 1, Issue:5

    Topics: Animals; Biphenyl Compounds; Callithrix; Fibrinogen; Guinea Pigs; Humans; In Vitro Techniques; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Swine; Thrombosis

1999